Reviewed by a licensed provider on November 15, 2026
Glutathione is a popular add-on at IV and wellness clinics. In 2026, a cluster of serious illnesses after compounded glutathione injections led FDA and CDC to issue warnings and several pharmacies to recall products. The cause was specific, and it points to a question every patient can ask before a drip.
What happened
On August 27, 2026, FDA reminded compounding pharmacies not to use dietary-supplement-grade glutathione to make injectable drugs. FDA cited reports of “at least 30 patients” with adverse events after IV glutathione, including “fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms,” with some hospitalized (FDA, August 27, 2026).
CDC’s situation report, last updated September 15, 2026, counted more than 25 people sick across Texas, Washington, Florida and New York, with at least three hospitalized. CDC said the illnesses were “likely linked to elevated levels of endotoxins in the injected products” (CDC). Endotoxins are fragments of bacteria that can cause fever, chills and, at high levels, shock, even when no live bacteria remain.
The recalls, including a Myers’ Cocktail
Three Texas pharmacies recalled products to the patient level:
- Victory Medical Center Pharmacy, Austin (FDA recall notice, August 5, 2026)
- Optimal Balance Pharmacy, Houston, which shipped to patients in 14 states (FDA recall notice, August 19, 2026)
- Centric Compounding, Houston, whose recall also covered Myers’ Cocktail and immune-blend IV products (FDA recall notice, September 11, 2026)
That last recall matters for anyone who gets IV therapy. The risk follows the ingredient, not the name on the drip menu. A drip called something else can carry the same problem.
The lesson: ingredient grade matters for anything that goes in a vein
Glutathione is sold everywhere as an oral supplement, and supplement-grade powder is made to supplement standards. Anything injected or infused must be sterile and made from ingredients suitable for injection. FDA’s instruction to clinicians was one sentence: “Health care professionals should check with their compounders regarding the source of the glutathione used to make injectable drugs for their patients” (FDA). CDC was blunter: “Do not administer injectable glutathione products that were compounded using dietary supplement grade ingredients” (CDC).
Three questions to ask before any glutathione drip or injection
Wherever you get IV therapy, these are fair questions:
- Which pharmacy prepared it? A clinic should be able to give you a name.
- Was the glutathione pharmaceutical grade, not dietary-supplement grade?
- Is this lot part of any recall? You can check it yourself; see how to check whether a compounded medication was recalled.
If you had a glutathione injection or drip and developed fever, chills, nausea, dizziness or a drop in blood pressure afterward, contact the clinic that gave it, and seek emergency care for severe symptoms. You or your clinician can report the reaction to FDA’s MedWatch program.
At Revive
IV therapy at Revive Medical Care is provider-supervised, and you are welcome to ask us any of the three questions above before your drip. See the IV menu or contact us.
Sources
- FDA, FDA reminds compounders not to use dietary supplement grade glutathione in injectables (August 27, 2026)
- CDC, Current situation: healthcare-associated infections (updated September 15, 2026)
- FDA recall notices: Victory Medical Center Pharmacy (August 5, 2026); Optimal Balance Pharmacy (August 19, 2026); Centric Compounding (September 11, 2026)
- FDA, MedWatch
Compounded medications are not FDA-approved. This article is general information, not medical advice, and is not intended to diagnose, treat, cure, or prevent any disease.
General wellness information, not medical advice. Individual results vary. Treatments require evaluation by a licensed provider.
